Featured Archives - Page 12 of 20

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

May 9, 2025

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

May 8, 2025

Bain Capital, Botanic Properties Acquire Bedford Site for Biomanufacturing Redevelopment

May 7, 2025

THIS WEEK'S STORIES

Ansa Biotechnologies Launches Early Access Program for 50 kb Synthetic DNA, Setting New Benchmark in Genomic Research

May 6, 2025

Neurology Center of New England Sees 156% Surge in Patient Payments with eClinicalWorks and healow Technologies

May 8, 2025

Twist Bioscience and Ginkgo Bioworks Revise Collaboration, Granting Twist Key Long DNA Technology License

May 8, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Featured

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

Bain Capital, Botanic Properties Acquire Bedford Site for Biomanufacturing Redevelopment

MassBio Warns of Looming Crisis in U.S. Biotech Sector as Federal Cuts and Trade Barriers Mount

EmPRO Insurance Expands into Massachusetts with Boston Office, Strengthening Northeast Presence

Most Read

GSK and Lifetime Team Up to Raise Awareness of Meningitis Through New Original Movie

What’s a fair price for a drug that’s never developed?

QuantHealth Launches First Clinical AI Foundation Model for Life Sciences Industry

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

EDITOR PICKS

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

Bain Capital, Botanic Properties Acquire Bedford Site for Biomanufacturing Redevelopment

THIS WEEK'S STORIES

Ansa Biotechnologies Launches Early Access Program for 50 kb Synthetic DNA, Setting New Benchmark in Genomic Research

Neurology Center of New England Sees 156% Surge in Patient Payments with eClinicalWorks and healow Technologies

Twist Bioscience and Ginkgo Bioworks Revise Collaboration, Granting Twist Key Long DNA Technology License

POPULAR CATEGORY

ABOUT US

FOLLOW US